Acquired inhibitors to the coagulation factor XII associated with liver disease

American Journal of Gastroenterology

Volumn 94, Issue 9, 1999, Pages 2551-2553

  Chalkiadakis, G ^a,b   Kyriakou, D ^a   Oekonomaki, E ^a   Tsiaoussis, J ^a   Alexandrakis, M ^a   Vasilakis, S ^a   Kouroumalis, E ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING INHIBITOR; CORTICOSTEROID;

ADULT; ANTIBODY DETECTION; ANTICOAGULATION; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HEMOPHILIA; HUMAN; LIVER DISEASE; LIVER LOBECTOMY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL;

ADULT; BLOOD COAGULATION FACTOR INHIBITORS; FACTOR XII; FEMALE; HEPATITIS, CHRONIC; HUMANS; LIVER NEOPLASMS; MIDDLE AGED;

EID: 0033199636     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.01317.x     Document Type: Article

References (21)

1. Margolius A. Circulating anticoagulants. A study to 40 cases and review of the literature. Medicine 1961;40:145.
2. Feinstein DI, Rapaport SI. Acquired inhibitors of blood coagulation. Prog Hematol 1972;1:75.
3. Schlieder MA, et al. A clinical study of lupus anticoagulant. Blood 1976;48:499.
4. Orris DJ, Lewis JH, Spero JA, et al. Blocking coagulation inhibitors in children taking penicillin. J Pediatr 1980;97:426.
5. Thiagarajan P, et al. Monoclonal immunoglobulin M coagulation inhibitor with phospholipid specificity. J Clin Invest 1980;66:3397.
6. Breckenridge RT, Ratnoff OD. Studies of the site of action of a circulating anticoagulant in SLE. Am J Med 1963;35:813.
7. Shapiro SS. The immunologie character of acquired inhibitors of antihaemophilic globulins and the kinetics of their interaction, with factor VIII. Scand J Haematol (in press).
8. Ingram GIC. Four cases of acquired von Willebrand's syndrome. Br J Hematol 1971;21:189.
9. Graham JE. Immunochemical characterization of a human antibody to factor XIII. Blood 1973;41:661.
10. Stern DM, Nossel HL, Owen J. Acquired antibody to factor XI in a patient with cogenital factor XI deficiency. J Clin Invest 1982;69:1270.
11. Jaeger U, Kapiotis S, Pabinger I, et al. Transient lupus anti-coagulant associated with hypoprothrombinemia and factor XII deficiency following adenovirus infection. Ann Hematol 1993;67:95-9.
12. Kleniewski J, Donaldson VH. Endothelial cells produce a substance that inhibits contact activation of coagulation by blocking the activation of Hageman factor. Proc Natl Acad Sci USA 1993;90:198-202.
13. Fucich LF, Cheles MK, Thung SN, et al. Primary metastatic hepatic carcinoma. An immunohistochemical study of 34 cases. Arch Pathol Lab Med 1994; 118:927-30.
14. Konoshima T, Terada H, Kokumai M, et al. Studies on inhibitors of skin tumor promotion, XII. Rotenoids from Amorpha fruticosa. J Nat Prod 1993;56:843-8.
15. Ratnoff ÖD, Gleich GJ, Shurin SB, et al. Inhibition of the activation of hageman factor (FXII) by eosinophils and eosinophilic constituents. Am J Hematol 1993;42:138-45.
16. Colman RW. Factor XII activation and inhibition in inflammation. Agents Actions 1993;42(suppl): 125-43.
17. Halbmayer WM, Haushofer A, Schon R, et al. The prevalence of moderate and severe FXII deficiency among the normal population: Evaluation of the incidence of FXII deficiency among 300 healthy blood donors. Thromb Haemost 1994;71: 68-72.
18. Cronberg S, Nilson IM. Circulating anticoagulant against factors XI and XII together with massive spontaneous platelet aggregation. Scand J Haematol 1973;10:309.
19. Leone G, Acorra F, Boni P. Circulating anticoagulant against factor XI and thrombocytopenia with platelet aggregation inhibition in systemic lupus erythematosus. Acta Haematol 1977;58:240.
20. Turgeon ML. Circulating anticoagulants. In: Clinical haematology, 2nd ed. Boston: Little, Brown, and Company 1993: 388-9.
21. Hampton JW. Leukocyte anticoagulant with myelogenous leukemia. Am J Med 1970;48:408.